Nexalin Technology regains Nasdaq bid price compliance
Get Alerts NXL Hot Sheet
Join SI Premium – FREE
Nexalin Technology, Inc. (NASDAQ: NXL) announced it has received written confirmation from Nasdaq that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
Nasdaq confirmed that the closing bid price of the company's common stock remained above the $1.00 per share minimum for 21 consecutive trading days, from August 31 through September 29, 2026, following a previously announced reverse stock split. The confirmation is dated September 30, 2026.
The confirmation follows a September 25, 2026, decision by the Nasdaq Hearings Panel granting the company's request for continued listing. Under the terms of that decision, Nexalin must also demonstrate compliance with the minimum $2.5 million stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1) on or before January 4, 2027.
The company's continued listing remains subject to the Panel's conditions, including prompt notification of any significant events that may affect compliance during the exception period. The Panel has reserved the right to reconsider the terms of the exception. Nexalin stated there is no assurance it will be able to satisfy the stockholders' equity requirement within the required timeframe.
"We appreciate the Panel's decision and are pleased to have satisfied the bid price requirement," said Mark White, Chief Executive Officer of Nexalin. "Our primary focus remains on the growing momentum across our business."
According to a statement from the company, Nexalin recently announced a distribution agreement covering Brazil and six additional South American markets and is continuing to advance its U.S. clinical programs, including a pivotal HALO™ Clarity clinical trial in insomnia, as it pursues FDA marketing authorization of its neurostimulation technology.
You May Also Be Interested In
- Wah Fu Education rebrands, adds "Technology" to its name
- Entera Bio to present EB613 Phase 3 study design at ASBMR meeting
- Securitize launches tokenized U.S. stock trading on Solana
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share